Ibex Medical Analytics Stock

IBEX is a Medical technology manufacturer that develops AI-powered diagnostic solutions to help pathologists.

Sign up today and learn more about Ibex Medical Analytics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Ibex Medical Analytics Stock

Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis, and machine learning, and apply it to cancer diagnostics in digital pathology. Today, Ibex is a multidisciplinary team comprised of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.

Funding History

March 2017$2.6M
March 2019$11.0M
March 2021$38.0M
November 2022$10.0M
March 2023$1.5M
September 2023$55.0M


Chief Commercial Officer

Stuart Shand


Dr. Douglas Clark

Chief Scientific Officer

Daphna Laifenfeld

Board Member

Gil Goren

Co-Founder & CEO

Joseph Mossel

Board Member

Will Gibbs

CTO & Co-Founder

Chaim Linhart


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: